<qa>  What is the primary objective of the investigators?The investigators primary objective is to compare the effectiveness of epsilon-aminocaproic acid EACA and tranexamic acid TA in reducing bleeding and transfusion in cardiac surgery, with the hypothesis that TA is more effective. The investigators also seek to further examine the clinical benefits and adverse effects profiles of epsilon-aminocaproic acid and tranexamic acid. 